In a statement on Tuesday, BHIVA and EAGA stated how treatment as prevention reduces HIV transmissions. By using HIV drugs to reduce the levels of the virus in their system people with HIV can become virtually non-infectious.
Deborah Jack, chief executive of NAT said: “A number of people with HIV want to start treatment early to lessen the chances of passing the virus on, meaning less worry for them but also fewer HIV transmissions, saving the NHS many hundreds of thousands of pounds.
“NAT approached BHIVA and EAGA to investigate the scientific basis for treatment as prevention. It’s great to see this work come to fruition and to see these respected medical bodies endorse treatment as a way to tackle the rising numbers of people living with HIV in the UK.